11.07.2015 Views

FINAL PROGRAM - American Society of Gene & Cell Therapy

FINAL PROGRAM - American Society of Gene & Cell Therapy

FINAL PROGRAM - American Society of Gene & Cell Therapy

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

13 th AnnUAL MEETing | Washington, DC USA May 19-22, 2010123Abstract DirectorySaturday, May 22, 2010Oral Abstract Session 412Cardiovascular <strong>Gene</strong> & <strong>Cell</strong> <strong>Therapy</strong>11:00 AM - 1:00 PMRoom: Wilson ABC596 11:00 AMSystemic Delivery <strong>of</strong> AAV2/9 Vectors Improve Cardiac Function inPompe DiseaseDarin J. Falk, Meghan S. Soustek, Cathryn S. Mah, Denise A. Cloutier, Sean A. Germain,Barry J. Byrne.597 11:15 AMCoordinated Co-Expression <strong>of</strong> VEGF 164and PDGF-BB PreventsAberrant Angiogenesis and Accelerates Vascular StabilizationRoberto Gianni-Barrera, Silvia Reginato, Thomas Wolff, Lorenz Gürke, Michael Heberer,Andrea Banfi.598 11:30 AMMitral Valve Disease Is Due to Abnormal Collagen Structure in CanineMucopolysaccharidosis I and VII and Can Be Reduced with NeonatalIntravenous Injection <strong>of</strong> a Gamma Retroviral VectorKatherine P. Ponder, Meg M. Sleeper, Susan Wu, Patricia O’Donnell, Mark E. Haskins.599 11:45 AMAAV9-Mediated proBNP Delivery Improves Diastolic Performance ina Model <strong>of</strong> Spontaneous Hypertensive RatsJason M. Tonne, Jarryd M. Campbell, Diego Bellavia, Elise A. Oehler, Fernando L. Martin,Alessandro Cataliotti, John C. Burnett, Yasuhiro Ikeda.600 12:00 PMIn Vivo Over-Expression <strong>of</strong> a b-Adrenergic Receptor Kinase InhibitorUsing scAAV6-Mediated Molecular Cardiac Surgery with RecirculatingDelivery (MCARD) Enhances Cardiac FunctionJaBaris D. Swain, Michael G. Katz, Anthony Fargnoli, Marina Sumaroka, CatherineTomasulo, Mihail Petrov, James J. Pilla, Hansell H. Stedman, Walter J. Koch, JosephRabinowitz, Charles R. Bridges.601 12:15 PMAAV-Mediated SERCA2a Expression Improves theElectrocardiographic Pr<strong>of</strong>ile <strong>of</strong> Aged mdx MiceJin-Hong Shin, Brian P. Bostick, Yongping Yue, Roger J. Hajjar, Dongsheng Duan.602 12:30 PMRNAi-Mediated Knockdown <strong>of</strong> HMG CoA Reductase In Vitro and InVivo Increases Transgene Expression from Genomic LDLR Mini-<strong>Gene</strong>VectorsOlivia C. Hibbitt, Sarina Agkatsev, Carina Owen, Len Seymour, Keith M. Channon,Richard Wade-Martins.603 12:45 PMSDF-1a-Engineered <strong>Cell</strong>-Based <strong>Therapy</strong> for Diabetic Wound HealingZhao-Jun Liu, Runxia Tian, Weijun An, Ying Zhuge, Yan Li, Hongwei Shao, Bianca Habib,Omaida C. Velazquez.Oral Abstract Session 413Cancer-Oncolytic Viruses II11:00 AM - 1:00 PMRoom: Marriott Ballroom Salons 2 & 3604 11:00 AMHigh Resolution Analysis <strong>of</strong> the Intratumoral Spread <strong>of</strong> anIntravenously Administered Oncolytic VirusShruthi Naik, Rebecca Nace, Elizabeth Hadac, Glen Barber, Stephen J. Russell.605 Abstract Withdrawn191 11:15 AMA Comparative Study <strong>of</strong> Stem <strong>Cell</strong>-Based <strong>Cell</strong> Carrier Systems for theSystemic Delivery <strong>of</strong> an Oncolytic Adenovirus for Antiglioma <strong>Therapy</strong>Matthew A. Tayler, Atique U. Ahmed, Ilya V. Ulasov, Irina Y. Balyasnikova, Maciej S.Lesniak.606 11:30 AMCombination <strong>of</strong> Anti Angiogenic Cancer <strong>Therapy</strong> with SystemicOncolytic Virotherapy To Treat Established TumorsTimothy Kottke, Ge<strong>of</strong>f Hall, Jose Pulido, Rosa Diaz, Jill Thompson, DebabrataMukhopadhyay, Heung Chong, Peter Selby, Matt C<strong>of</strong>fey, Hardev Pandha, John Chester,Alan Melcher, Kevin Harrington, Richard Vile.607 11:45 AMThe Type III Interferon IL-28 Mediates Anti Tumor Efficacy <strong>of</strong>Oncolytic VSV in a Fully Immune Competent ModelPhonphimon Wongthida, Rosa Diaz, Feorillo Galivo, Timothy Kottke, Jill Thompson, JosePulido, Kevin Pavelko, Larry Pease, Alan Melcher, Richard Vile.608 12:00 PMA New Oncolytic Herpes Simplex Virus That Synergizes with SmallMolecule Inhibitors <strong>of</strong> PI3K/Akt To Treat Malignant GliomaRyuichi Kanai, Matthew Gardner, Hiroaki Wakimoto, Robert L. Martuza, Samuel D.Rabkin.609 12:15 PMImproving the Lytic Capacity <strong>of</strong> a Conditionally ReplicativeAdenoviruses by Incorporating Promoter Elements Responsive toTumor Environmental ConditonsDiego L. Viale, Veronica M. Lopez, Eduardo G. Cafferata, David Gould, Yuti Chenajovsky,Osvaldo L. Podhajcer.610 12:30 PMDefining the Role <strong>of</strong> Innate Immune Mechanisms in the Efficacy <strong>of</strong>Oncolytic VSV Virotherapy in a Fully Immune Competent ModelPhonphimon Wongthida, Rosa Diaz, Feorillo Galivo, Timothy Kottke, Jill Thompson, JosePulido, Alan Melcher, Richard Vile.611 12:45 PMDifferential Effects <strong>of</strong> VSV and Cyclophosphamide on NK <strong>Cell</strong>sLeads to Antagonistic Effects on Anti-Tumor <strong>Therapy</strong> <strong>of</strong> a MurineMesothelioma ModelCandice L. Willmon, Jill Thompson, Timothy Kottke, Stephen Albelda, Richard Vile.Saturday, May 22 nd

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!